These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2184505)

  • 1. Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy.
    Troke PF; Andrews RJ; Pye GW; Richardson K
    Rev Infect Dis; 1990; 12 Suppl 3():S276-80. PubMed ID: 2184505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azole antifungal agents.
    Bodey GP
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New antifungal agents for the systemic mycoses.
    Ringel SM
    Mycopathologia; 1990 Feb; 109(2):75-87. PubMed ID: 2157984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
    Tucker RM; Denning DW; Hanson LH; Rinaldi MG; Graybill JR; Sharkey PK; Pappagianis D; Stevens DA
    Clin Infect Dis; 1992 Jan; 14(1):165-74. PubMed ID: 1315160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azole antifungal drugs: old and new.
    Dismukes WE
    Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058
    [No Abstract]   [Full Text] [Related]  

  • 6. Current and emerging azole antifungal agents.
    Sheehan DJ; Hitchcock CA; Sibley CM
    Clin Microbiol Rev; 1999 Jan; 12(1):40-79. PubMed ID: 9880474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
    Lyman CA; Walsh TJ
    Drugs; 1992 Jul; 44(1):9-35. PubMed ID: 1379913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.
    Wildfeuer A; Laufen H; Schmalreck AF; Yeates RA; Zimmermann T
    Mycoses; 1997 Nov; 40(7-8):259-65. PubMed ID: 9476508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility of yeasts].
    Wildfeuer A; Laufen H; Schmalreck AF; Yeates RA; Zimmermann T
    Mycoses; 1996; 39 Suppl 2():51-7. PubMed ID: 9198746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice.
    Kamberi P; Atsuro H; Takayoshi T; Masaru N
    Chemotherapy; 1998; 44(1):55-62. PubMed ID: 9444410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluconazole: a new antifungal agent.
    Kowalsky SF; Dixon DM
    Clin Pharm; 1991 Mar; 10(3):179-94. PubMed ID: 2040125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azole drug resistance in yeasts.
    Johnson EM; Warnock DW
    J Antimicrob Chemother; 1995 Nov; 36(5):751-5. PubMed ID: 8626255
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antifungal agent resistance of yeasts of clinical significance].
    Odds FC
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():56-7. PubMed ID: 9441307
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifungal agents. Part II. The azoles.
    Terrell CL
    Mayo Clin Proc; 1999 Jan; 74(1):78-100. PubMed ID: 9987539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azole antifungals: 35 years of invasive fungal infection management.
    Allen D; Wilson D; Drew R; Perfect J
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):787-98. PubMed ID: 25843556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azoles and AIDS.
    Larsen RA
    J Infect Dis; 1990 Sep; 162(3):727-30. PubMed ID: 2167339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
    Borst A; Raimer MT; Warnock DW; Morrison CJ; Arthington-Skaggs BA
    Antimicrob Agents Chemother; 2005 Feb; 49(2):783-7. PubMed ID: 15673768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.